Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P43026 (
lipopolysaccharide
)
62,215
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Animals develop in the presence of complex microbial communities, and early host responses to these microbes can influence key aspects of development, such as maturation of the immune system, in ways that impact adult physiology. We previously showed that the zebrafish intestinal alkaline phosphatase (
ALPI
) gene alpi.1 was induced by Gram-negative bacterium-derived
lipopolysaccharide
(
LPS
), a process dependent on myeloid differentiation primary response gene 88 (MYD88), and functioned to detoxify
LPS
and prevent excessive host inflammatory responses to commensal microbiota in the newly colonized intestine. In the present study, we examined whether the regulation and function of
ALPI
were conserved in mammals. We found that among the mouse
ALPI
genes, Akp3 was specifically upregulated by the microbiota, but through a mechanism independent of
LPS
or MYD88. We showed that disruption of Akp3 did not significantly affect intestinal inflammatory responses to commensal microbiota or animal susceptibility to Yersinia pseudotuberculosis infection. However, we found that Akp3(-/-) mice acquired
LPS
tolerance during postweaning development, suggesting that Akp3 plays an important role in immune education. Finally, we demonstrated that inhibiting
LPS
sensing with a mutation in CD14 abrogated the accelerated weight gain in Akp3(-/-) mice receiving a high-fat diet, suggesting that the weight gain is caused by excessive
LPS
in Akp3(-/-) mice.
...
PMID:Intestinal alkaline phosphatase deficiency leads to lipopolysaccharide desensitization and faster weight gain. 2534 35
Vitamin D insufficiency is associated with a greater risk of osteoporosis and also influences skeletal muscle functions, differentiation, and development. The principal function of vitamin D in calcium homeostasis is to increase the absorption of calcium from the intestine, and the level of alkaline phosphatase (ALP) activity, a differentiation marker for intestinal epithelial cells, is regulated by vitamin D. Intestinal-type ALP is expressed at a high concentration in the brush border membrane of intestinal epithelial cells, and is known to be affected by several kinds of nutrients. Recent reviews have highlighted the importance of intestinal-type ALP in gut homeostasis. Intestinal-type ALP controls bacterial endotoxin-induced inflammation by dephosphorylating
lipopolysaccharide
and is a gut mucosal defense factor. In this study, we investigated the influence of vitamin D on the expression of 2 types of alternative mRNA variants encoding the human
alkaline phosphatase, intestinal
(
ALPI
) gene in human Caco-2 cells as an in vitro model of the small intestinal epithelium. After treatment with 1-alpha,25-dihydroxyvitamin D
3
, the biologically active form of vitamin D
3
, there were significant increases in the ALP activities of Caco-2 cells. Inhibitor and thermal inactivation experiments showed that the increased ALP had properties of intestinal-type ALP. Reverse transcription-polymerase chain reaction analysis revealed that expression of the 2 types of alternative mRNA variants from the
ALPI
gene was markedly enhanced by vitamin D in Caco-2 cells. In conclusion, these findings agree with the hypothesis: vitamin D up-regulated the expression of 2 types of human intestinal alkaline phosphatase alternative splicing variants in Caco-2 cells; vitamin D may be an important regulator of
ALPI
gene expression in gut homeostasis.
...
PMID:1-alpha,25-Dihydroxyvitamin D
3
up-regulates the expression of 2 types of human intestinal alkaline phosphatase alternative splicing variants in Caco-2 cells and may be an important regulator of their expression in gut homeostasis. 2893 66
Herein, we report the first identification of biallelic-inherited mutations in
ALPI
as a Mendelian cause of inflammatory bowel disease in two unrelated patients.
ALPI
encodes for intestinal phosphatase alkaline, a brush border metalloenzyme that hydrolyses phosphate from the lipid A moiety of lipopolysaccharides and thereby drastically reduces Toll-like receptor 4 agonist activity. Prediction tools and structural modelling indicate that all mutations affect critical residues or inter-subunit interactions, and heterologous expression in HEK293T cells demonstrated that all
ALPI
mutations were loss of function.
ALPI
mutations impaired either stability or catalytic activity of
ALPI
and rendered it unable to detoxify
lipopolysaccharide
-dependent signalling. Furthermore,
ALPI
expression was reduced in patients' biopsies, and
ALPI
activity was undetectable in
ALPI
-deficient patient's stool. Our findings highlight the crucial role of
ALPI
in regulating host-microbiota interactions and restraining host inflammatory responses. These results indicate that
ALPI
mutations should be included in screening for monogenic causes of inflammatory bowel diseases and lay the groundwork for
ALPI
-based treatments in intestinal inflammatory disorders.
...
PMID:Human ALPI deficiency causes inflammatory bowel disease and highlights a key mechanism of gut homeostasis. 2956 97